This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignees: Historx, Inc., Novartis Ag. Active years: 2012-2016.
Location History:
- New Haven, CT (US) (2013)
- Orange, CT (US) (2012 - 2016)
Company Filing History:
Years Active: 2012-2016
Title: **Innovator Spotlight: Dongxiao Wang**
Introduction
Dongxiao Wang is a prominent inventor based in Orange, Connecticut, who holds an impressive portfolio of three patents. His work primarily focuses on advancements in biomarker expression and quantitative immunoassays, contributing significantly to the fields of biomedical research and diagnostics.
Latest Patents
Dongxiao Wang's latest patents reflect his innovative approach to enhancing the accuracy and reproducibility of medical diagnostics. His first patent, titled "Reproducible Quantification of Biomarker Expression," outlines a method for reliably quantifying biomarker expression present in tissue samples. This invention ensures that biomarker expression scores are achieved independently of the instrument used, its location, or the operator's influence.
In addition, his second patent titled "Methods and System for Validating Sample Images for Quantitative Immunoassays" describes a comprehensive method to automatically assess the quality of slide-mounted tissue samples. This includes receiving a digital image of a magnified sample portion and determining quantitative quality indicators. These indicators are then compared against established quality thresholds. If any indicators fail to meet minimum acceptable quality standards, the sample is deemed unsuitable for further evaluation. This cutting-edge invention not only streamlines the assessment process but also facilitates user oversight through an interactive interface.
Career Highlights
Throughout his career, Dongxiao Wang has made meaningful contributions to notable companies such as Historx, Inc. and Novartis AG. His roles within these organizations have allowed him to leverage his expertise in developing innovative solutions and improve pathological evaluation methods.
Collaborations
Dongxiao has collaborated with skilled professionals in his field, including colleagues Robert Pinard and Gregory R. Tedeschi. Their combined expertise has further advanced the research and development efforts in diagnostic technologies.
Conclusion
Dongxiao Wang continues to make strides in the realm of medical diagnostics through his inventive methodologies. His dedication to enhancing biomarker quantification and sample assessment processes exemplifies the spirit of innovation that drives improvements in healthcare. As he progresses in his career, his contributions are sure to inspire future advancements within the industry.